Luxdegalutamide (ARV-766) is an orally active protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), which can degrade AR resistance related mutants, including T878/H875/L702 mutants. Luxdegalutamide has anti-tumor activity and can be used in the study of castration resistant prostate cancer[1][2].
Molecular Weight:
807.95
Purity:
98.99
CAS Number:
[2750830-09-0]
Formula:
C45H54FN7O6
Target:
Androgen Receptor,PROTACs
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted